Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals
Author(s): Faria R, Woods B, Griffin S, Palmer S, Sculpher M, Ryder SD
Aliment Pharmacol Ther. 2016;44(8):866-76.
NIHR Acknowledged: Yes
|Dr Steve Ryder|